InvestorsHub Logo
Followers 62
Posts 7582
Boards Moderated 1
Alias Born 01/02/2003

Re: dogn post# 385979

Thursday, 08/11/2022 4:52:13 PM

Thursday, August 11, 2022 4:52:13 PM

Post# of 427311
Dogn...Thank you for this informative study.

It looks as though MD2119 is at least as effective(or more) than Vascepa and at least as safe....and eminently approvable by the FDA!...Amarin should now consider applying to the FDA for approval of MD2119 with an eye to eventually withdrawing Vascepa from the U.S. market and replacing it with MD2119.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News